GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,200,000 | -0.2% | 257,282 | -0.1% | 0.90% | +12.7% |
| Q1 2022 | $11,221,000 | -0.3% | 257,587 | +0.9% | 0.80% | +8.9% |
| Q4 2021 | $11,260,000 | +12.9% | 255,338 | -2.1% | 0.73% | +9.6% |
| Q3 2021 | $9,971,000 | -6.0% | 260,945 | -2.0% | 0.67% | -1.2% |
| Q2 2021 | $10,607,000 | +10.8% | 266,377 | -0.7% | 0.68% | +6.6% |
| Q1 2021 | $9,577,000 | +0.9% | 268,324 | +4.1% | 0.64% | -3.3% |
| Q4 2020 | $9,487,000 | -12.9% | 257,791 | -11.0% | 0.66% | -11.7% |
| Q3 2020 | $10,898,000 | -14.3% | 289,524 | -7.1% | 0.74% | -15.2% |
| Q2 2020 | $12,715,000 | +1.3% | 311,718 | -6.0% | 0.88% | -8.6% |
| Q1 2020 | $12,558,000 | -29.4% | 331,445 | -12.4% | 0.96% | 0.0% |
| Q4 2019 | $17,775,000 | +2.8% | 378,263 | -6.6% | 0.96% | -0.5% |
| Q3 2019 | $17,293,000 | +0.0% | 405,167 | -6.2% | 0.96% | +2.9% |
| Q2 2019 | $17,286,000 | -7.5% | 431,933 | -3.4% | 0.94% | -3.8% |
| Q1 2019 | $18,682,000 | +8.4% | 447,048 | -0.9% | 0.98% | +5.0% |
| Q4 2018 | $17,233,000 | -8.5% | 451,017 | -3.8% | 0.93% | +13.6% |
| Q3 2018 | $18,826,000 | -2.7% | 468,657 | -2.3% | 0.82% | -4.1% |
| Q2 2018 | $19,342,000 | +2.4% | 479,840 | -0.8% | 0.85% | +3.6% |
| Q1 2018 | $18,893,000 | +17.0% | 483,576 | +6.2% | 0.82% | +19.4% |
| Q4 2017 | $16,154,000 | -18.5% | 455,445 | -6.7% | 0.69% | -19.3% |
| Q3 2017 | $19,810,000 | -7.9% | 487,945 | -2.2% | 0.85% | -15.9% |
| Q2 2017 | $21,503,000 | +0.3% | 498,684 | -2.0% | 1.02% | +2.4% |
| Q1 2017 | $21,446,000 | +10.2% | 508,691 | +0.7% | 0.99% | +11.0% |
| Q4 2016 | $19,453,000 | -17.7% | 505,156 | -7.8% | 0.89% | -16.3% |
| Q3 2016 | $23,636,000 | +20.2% | 548,032 | +20.8% | 1.07% | +2.6% |
| Q2 2016 | $19,669,000 | +6.9% | 453,848 | -0.0% | 1.04% | +4.9% |
| Q1 2016 | $18,407,000 | +3.7% | 453,939 | +3.2% | 0.99% | +26.9% |
| Q4 2015 | $17,745,000 | +1.5% | 439,787 | -3.3% | 0.78% | -1.5% |
| Q3 2015 | $17,478,000 | -54.8% | 454,566 | -67.4% | 0.79% | +19725.0% |
| Q2 2015 | $38,704,000 | +83.9% | 1,395,822 | +206.1% | 0.00% | -99.4% |
| Q1 2015 | $21,046,000 | +15.7% | 456,041 | +7.2% | 0.70% | -32.8% |
| Q4 2014 | $18,183,000 | +23.8% | 425,444 | +33.2% | 1.05% | +18.0% |
| Q3 2014 | $14,684,000 | -8.4% | 319,418 | +6.5% | 0.89% | -8.6% |
| Q2 2014 | $16,038,000 | +7.6% | 299,897 | +7.5% | 0.97% | -2.2% |
| Q1 2014 | $14,902,000 | +9.1% | 278,902 | +9.0% | 0.99% | -1.8% |
| Q4 2013 | $13,663,000 | +19.6% | 255,906 | +12.4% | 1.01% | +7.9% |
| Q3 2013 | $11,421,000 | +10.5% | 227,639 | +10.0% | 0.94% | -7.9% |
| Q2 2013 | $10,337,000 | – | 206,872 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |